Asia
Taiwan
EffPha provides strategic consulting services and full CRO services, including clinical operation, regulatory affairs, data management and statistical analysis.
Client: Pharmaceutical/ Biotech Company, Goverment Funded Research Center
Drug Type: Small Molecular/Botanical Drug, Biologics
Indication: Advanced Solid Tumors, Cancer, Diabetes Mellitus, Sepsis, Dermatology/ Inflammatory
China
EffPha supports clinical study and drug registration in Taiwan.
Client: Pharmaceutical Company
Drug Type: Small Molecular, Botanical Drug
Indication:Cancer, Stroke, Pain, Focal Segmental Glomerulosclerosis (FSGS)
Japan
Client: Pharmaceutical/Biotech Company, Venture
Investment Firm
Drug Type: Liposome
Indication: Inflammatory Disease
South Korea
EffPha supports clinical study and drug registration in Taiwan.
Client: Pharmaceutical/Biotech Company, Venture Investment Firm
Drug Type: Small Molecular Drug, Biologics
Indication: Cancer
India
Client: Generic Pharmaceutical Company
Drug type: Small molecular
Indication: Cardiovascular Disease
America
US
EffPha serves as the regulatory representative in the US and provides regulatory affairs services to the clients.
Client: Pharmaceutical/Biotech Company, Venture Investment Firm
Drug Type: Small Molecular, Botanical Drug
Indication: Advanced Solid Tumors, Cancer, Diabetes Mellitus, Dermatitis
Canada
Client: Pharmaceutical Company, Venture Investment Firm
Europe
United Kingdom
EffPha has partners that provide full CRO services in Europe.
Partner: Clinical Management Company
Drug Type: Small Molecular
Indication: Headache
Australia
Australia
EffPha supports clinical study and regulatory application in Taiwan.
Client: Pharmaceutical Company
Drug Type: Small Molecular Drug
Indication: Cancer Pain